Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 3.205
+0.055 (1.75%)
Oct 31, 2025, 12:59 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 406.44 million as of October 31, 2025. Its market cap has increased by 93.61% in one year.
Market Cap
406.44M
Enterprise Value
354.21M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.21
Market Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 406.44M, a decrease of -27.72%. That is a compound annual growth rate of -4.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 406.44M | 44.83% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | 1.59B | 186.78% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.29B |
| Getinge AB | 61.26B |
| Sectra AB | 59.07B |
| Medicover AB | 39.18B |
| Camurus AB | 37.14B |
| Asker Healthcare Group AB | 32.14B |
| BioArctic AB | 26.24B |
| AddLife AB | 24.93B |